MedTrace Logo

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

NCT01454297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1154

Last updated 2024-01-03

No results posted yet for this study

Summary

The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.

Conditions

Sponsors & Collaborators

  • Translational Genomics Research Institute

    collaborator OTHER

  • Spectrum Health Hospitals

    collaborator OTHER

  • Van Andel Research Institute

    collaborator OTHER

  • Multiple Myeloma Research Foundation

    lead OTHER

Principal Investigators

  • Daniel Auclair · Multiple Myeloma Research Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • United States
  • Canada
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01454297 on ClinicalTrials.gov